Andrew Feigin's guest appearances

Andrew Feigin

Help 4 HD Live!

HD Insights Podcast

Mary Edmondson

Vicki Wheelock

Gene Veritas

Victor Sung

Seth Rotberg

Ira Shoulson

Katie Jackson

Adam Vogel

Jason Evans

Catherine Martin

Emily Fisher

Jordan Schultz

Kate Miner

Cindy Moore

Veronica Ruiz

OwlTail

Dr. Andrew Feigin, Chair of the Huntington Study Group joined us to usher in 2020 and a new year of HD Insights Podcasts. Dr. Feigin is a professor of Neurology at NYU Langone Health and co-director of the Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders. He has been involved in HD research since his participation in the Venezuela Collaborative Research Group, which isolated the HD gene 25 years ago. In this episode, Dr. Feigin shares what the experience in Venezuela was like, his tenure at North Shore University Hospital on Long Island setting up a Huntington's disease clinic, and current initiatives he's leading with the Huntington Study Group. We also get an update on the SIGNAL trial from Dr. Feigin, who serves as the Principal Investigator on that trial.  To learn more about the Huntington Study Group and their current clinical trials and research, visit www.huntingtonstudygroup.org

Dr. Andrew Feigin, Chair of the Huntington Study Group joined us to usher in 2020 and a new year of HD Insights Podcasts. Dr. Feigin is a professor of Neurology at NYU Langone Health and co-director of the Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders. He has been involved in HD research since his participation in the Venezuela Collaborative Research Group, which isolated the HD gene 25 years ago. In this episode, Dr. Feigin shares what the experience in Venezuela was like, his tenure at North Shore University Hospital on Long Island setting up a Huntington's disease clinic, and current initiatives he's leading with the Huntington Study Group. We also get an update on the SIGNAL trial from Dr. Feigin, who serves as the Principal Investigator on that trial.  To learn more about the Huntington Study Group and their current clinical trials and research, visit <a href="https://huntingtonstudygroup.org" rel="nofollow" target="_blank">www.huntingtonstudygroup.org</a>

Episode 9 - Dr. Andrew Feigin (Huntington Study Group Chair)

Karen Elta Anderson

TUESDAY, SEPT 22, 2015 ~ 2:00 PM PST/5:00 PM ESTTonight we have two of our most favorite incredible special guests, Dr. Karen Elta Anderson, Director at Georgetown/MedStar HD Clinic and Dr. Andrew Feigin, Director at the HD Center North Shore-LIJ Health System. Both are such esteemed medical professionals and well loved by the families whose lives they touch. They are super stars of Huntington’s disease care and clinical trial investigators. We will be talking about LEGATO-HD, the HSG/Teva clinical trial of Laquinimod. This will be a scripted program, but I want our listeners to know that if you have any questions about this program, please feel free to type it into the chatroom here on BlogTalkRadio or Facebook message your questions to me and we will try to get the answers for you. Tune in for an amazing program to educate and inspire you. For more information about participating in LEGATO-HD study please talk to your physician or you may call the Huntington Study Group at 800-847-7671 or email at info@hsglimited.org

TUESDAY, SEPT 22, 2015 ~ 2:00 PM PST/5:00 PM EST Tonight we have two of our most favorite incredible special guests, Dr. Karen Elta Anderson, Director at Georgetown/MedStar HD Clinic and Dr. Andrew Feigin, Director at the HD Center North Shore-LIJ Health System. Both are such esteemed medical professionals and well loved by the families whose lives they touch. They are super stars of Huntington’s disease care and clinical trial investigators. We will be talking about LEGATO-HD, the HSG/Teva clinical trial of Laquinimod. This will be a scripted program, but I want our listeners to know that if you have any questions about this program, please feel free to type it into the chatroom here on BlogTalkRadio or Facebook message your questions to me and we will try to get the answers for you.  Tune in for an amazing program to educate and inspire you. For more information about participating in LEGATO-HD study please talk to your physician or you may call the Huntington Study Group at 800-847-7671 or email at info@hsglimited.org

The HD View ~ LEGATO-HD with Dr. Andrew Feigin & Dr. Karen Elta Anderson

FRIDAY, AUGUST 14, 2015: 2:00 PM ESTTonight we have a very special show with Dr. Andrew Feigin, Professor of Neurology and Director of the Huntington’s Disease Center at North Shore University Hospital and the Director of the Laboratory of Experimental Therapeutics for Movement Disorders at The Feinstein Institute for Medical Research of the North Shore – LIJ Health System in Manhasset, NY.  Dr. Feigin has been involved in HD clinical research for 20 years; he participated in the Venezuela HD project for 10 years beginning in 1993. We will be talking about the new clinical trial called SIGNAL. Tune into a vey exciting new clinical trial using a new approach - a monoclonal antibody called VX15.

FRIDAY, AUGUST 14, 2015: 2:00 PM EST Tonight we have a very special show with Dr. Andrew Feigin, Professor of Neurology and Director of the Huntington’s Disease Center at North Shore University Hospital and the Director of the Laboratory of Experimental Therapeutics for Movement Disorders at The Feinstein Institute for Medical Research of the North Shore – LIJ Health System in Manhasset, NY.  Dr. Feigin has been involved in HD clinical research for 20 years; he participated in the Venezuela HD project for 10 years beginning in 1993. We will be talking about the new clinical trial called SIGNAL. Tune into a vey exciting new clinical trial using a new approach - a monoclonal antibody called VX15.

The HD View with Dr. Andrew Feigin, MD